Alteration of Symbiosis Intestinal Microbiota on Patients With Anorexia Nervosa
INT-METAVOSA
Study of Translational Process of Relationship Between Intestinal Microbiota of Dysbiosis and the Psychic Symptoms of Anorexia Nervosa (Eating Disorders and Anxio-depression Disorders)
2 other identifiers
observational
120
1 country
1
Brief Summary
The purpose of this study will be to study the association between the level of psychic symptomatic of anorexia nervosa (AN) (intensity of food restriction, symptoms of anxiety and depression) and alteration of host environment symbiosis and the mechanism (dysbiosis of intestinal microbiota, increase of intestinal permeability, immunity alteration and low-grade inflammation).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2022
CompletedFirst Posted
Study publicly available on registry
November 30, 2022
CompletedStudy Start
First participant enrolled
May 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 1, 2026
November 24, 2025
November 1, 2025
2.3 years
November 14, 2022
November 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Eating Disorder
By Eating Disorder Inventory (EDI-3)
at baseline
Anxio-depressive symptomatologic assessements by HAD score
By HAD score
at baseline
Anxio-depressive symptomatologic assessements by scale of Beck BDI 13
By scale of Beck BDI 13
at baseline
Anxio-depressive symptomatologic assessements by LSAS Lieboweitz social anxiety scale
By LSAS Lieboweitz social anxiety scale
at baseline
Anxio-depressive symptomatologic assessements by MOCI
By Maudsley Obsessions and compulsions inventory (MOCI).
at baseline
Anxio-depressive symptomatologic assessements
By HAD score, scale of Beck BDI 13, LSAS Lieboweitz social anxiety scale, Maudsley Obsessions and compulsions inventory (MOCI).
at baseline
Physical exercise
By Global physical activity questionnaire (GPAQ)
at baseline
Biological parameter
By serum serotonin level
at baseline
Secondary Outcomes (16)
Diversity indice
at baseline
Intestinal permeability
at baseline
Immunity alteration
at baseline
Liver function
at baseline
BMI
at baseline
- +11 more secondary outcomes
Study Arms (2)
Anorexia patients
Hospitalized anorexia patients with body mass index \< 15.
Healthy controls
Health volunteers: 18 years or older with body mass index between 18.5 and 25.
Interventions
Eligibility Criteria
Hospitalized patients with anorexia nervosa for nutrition rehabilitation in the department of nutrition in Paul Brousse hospital (Villejuif) - APHP.
You may qualify if:
- For patients:
- Patients aged ≥18 years;
- Anorexia according to DSM-5 and CIDI (Composite International Diagnostic Interview);
- Body mass index (BMI) (P/T2) \< 15;
- Hospitalization for nutrition rehabilitation;
- Covered by a health insurance;
- Informed consent form signed.
- For Healthy Volunteers:
- Aged ≥18 years;
- \< BMI (P/T2) \< 25;
- Covered by a health insurance;
- Informed consent form signed.
You may not qualify if:
- For patients:
- Patients no-responding all criteria of DSM-5 or CIDI scores;
- Taken of antibiotic treatment 2 months / or laxativ 3 weeks before hospitalization;
- Somatic comorbidity should perturb intestinal microbiota (Crohn's disease, diabetes and all other chronic inflammatory diseases);
- Patients under guardianship;
- Patients covered by french AME scheme.
- For Healthy Volunteers:
- Any disease should perturb intestinal microbiota;
- Recent ponderal variation;
- Taken of antibiotic treatment 2 months or laxativ 3 weeks before hospitalization;
- Under guardianship;
- Covered by french AME scheme.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Assistance Publique - Hôpitaux de Parislead
- Fondation de Francecollaborator
Study Sites (1)
Service de Nutrition Clinique, Hôpital Paul Brousse (APHP)
Villejuif, 94800, France
Biospecimen
Stool sample will be collected for all of 2 types of subjects (patients and health volunteers).
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mouna HANACHI GUIDOUM, MD
Service de Nutrition Clinique, Hôpital Paul Brousse - APHP
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 14, 2022
First Posted
November 30, 2022
Study Start
May 23, 2024
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
October 1, 2026
Last Updated
November 24, 2025
Record last verified: 2025-11